Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elidel (pimecrolimus) vs vehicle for quality of life in moderate facial atopic eczema
2004-002688-25Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Elidel arm with Vehicle arm (2 arms). Primary endpoint: Change from baseline in QoLIAD score at 4 weeks. Started Jun 2005; status: completed.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-002688-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002688-25.